ALNY
Alnylam Pharmaceuticals, Inc.stockNASDAQ
At CloseNov 18, 2026 3:59:55 PM EST
149.48USD-4.486%(-7.02)2,518,169
Pre-marketNov 18, 2026 9:15:30 AM EST
156.90USD+0.256%(+0.40)
After-hoursNov 18, 2026 4:46:30 PM EST
149.58USD+0.067%(+0.10)
ALNY Financials
In Q3 FY 2026 (ended ), Alnylam Pharmaceuticals, Inc. (ALNY) reported revenue of $1.46B, net income of $2.17B, operating cash flow of $340.99M, and assets of $7.99B (filed ).
Loading business breakdowns…
